Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.
Authors: Moftakhar B; University of Rochester, Rochester, NY, USA. bmoftakhar@urmc.rochester.edu.; Wilmot Cancer Institute, University of Rochester Medical Center, 607 Elmwood Avenue, Box 704, Rochester, NY, 14642-0001, USA. bmoftakhar@urmc.rochester.edu., Lekkala M; University of Rochester, Rochester, NY, USA., Strawderman M; University of Rochester, Rochester, NY, USA., Smith TC; University of Rochester, Rochester, NY, USA., Meacham P; University of Rochester, Rochester, NY, USA., Fitzgerald B; University of Rochester, Rochester, NY, USA., Falkson CI; University of Rochester, Rochester, NY, USA., Dhakal A; University of Rochester, Rochester, NY, USA.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Sep; Vol. 183 (2), pp. 411-418. Date of Electronic Publication: 2020 Jul 15.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32671612
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Moftakhar+B%22">Moftakhar B</searchLink>; University of Rochester, Rochester, NY, USA. bmoftakhar@urmc.rochester.edu.; Wilmot Cancer Institute, University of Rochester Medical Center, 607 Elmwood Avenue, Box 704, Rochester, NY, 14642-0001, USA. bmoftakhar@urmc.rochester.edu.<br /><searchLink fieldCode="AU" term="%22Lekkala+M%22">Lekkala M</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Strawderman+M%22">Strawderman M</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Smith+TC%22">Smith TC</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Meacham+P%22">Meacham P</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+B%22">Fitzgerald B</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Falkson+CI%22">Falkson CI</searchLink>; University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dhakal+A%22">Dhakal A</searchLink>; University of Rochester, Rochester, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2020 Sep; Vol. 183 (2), pp. 411-418. <i>Date of Electronic Publication: </i>2020 Jul 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32671612
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-020-05793-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 411
    Titles:
      – TitleFull: Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moftakhar B
      – PersonEntity:
          Name:
            NameFull: Lekkala M
      – PersonEntity:
          Name:
            NameFull: Strawderman M
      – PersonEntity:
          Name:
            NameFull: Smith TC
      – PersonEntity:
          Name:
            NameFull: Meacham P
      – PersonEntity:
          Name:
            NameFull: Fitzgerald B
      – PersonEntity:
          Name:
            NameFull: Falkson CI
      – PersonEntity:
          Name:
            NameFull: Dhakal A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 183
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1